Visualitzant per matèria "Metastatic breast cancer"
Ara mostrant els elements 1-1 de 1
-
Palbociclib and trastuzumab for HER2-positive metastatic breast cancer: final overall survival results of cohort A and B of SOLTI-1303-PATRICIA trial
(ESMO Open, 2025-09-01)Background: The SOLTI-1303-PATRICIA trial (NCT02448420) is a phase II study investigating palbociclib and trastuzumab, with or without endocrine therapy, in hormone receptor (HR)-positive/human epidermal ...
